B

BioCrossroads

15 employees

BioCrossroads is a venture capital firm specializing in life sciences companies based in Indiana.

Investor insights

Sectors invested in

Biotechnology12
Health Care11
Software4
Pharmaceutical4
Therapeutics4
Medical Device3
Life Science3
Digital Customer Journey2
Diabetes2
Wellness2
Mobile Apps2
Marketing2
Customer Service2
SaaS2
Residential2
Agriculture2
Hardware2
Industrial Automation2
Autonomous Vehicles2
Farming2

Funding rounds participated in

$2M sweet spot round size

Most of their 22 investments are in rounds between $400K and $3M

Investor type

Venture Capital

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Financial Services
Health Care
Finance
Medical
Life Science
Venture Capital

Date founded

2002

Investments made

G

Gate Neurosciences, Inc. raised $25M on October 5, 2022

Investors: Thornapple River Capital, Innoviva and BioCrossroads

L

Lumavate raised $6M on January 31, 2022

Investors: Gutbrain Ventures, Allos Ventures and BioCrossroads

K

Kovina Therapeutics raised $2M on October 20, 2021

Investors: Elevate Ventures, Indiana University Research and Technology Corporation and BioCrossroads

N

Novosteo Inc raised $5.5M on January 13, 2021

Investors: Elevate Ventures, Purdue Research Foundation, Kairos Ventures and BioCrossroads

S

Sabanto raised $3M on December 24, 2020

Investors: DCVC Bio, Cavallo Ventures and BioCrossroads

M

MBX Biosciences, Inc. raised $35M on July 27, 2020

Investors: OrbiMed Advisors, Frazier Healthcare Partners, Indiana Philanthropic Venture Fund (IU PhV) and BioCrossroads

U

Undisclosed raised $5M on September 24, 2019

Investors: Cook Regentec, Casdin Capital, LLC, BioLife Solutions and BioCrossroads

S

Sabanto raised $2M on August 12, 2019

Investors: DCVC Bio and BioCrossroads

L

Lumavate raised $3M on June 12, 2019

Investors: Elevate Ventures and BioCrossroads

S

Scioto Biosciences, Inc raised $1.8M on May 21, 2018

Investors: Pathway Bioventures, Rev1 Ventures, Elevate Ventures and BioCrossroads

Funding rounds raised

Total raised

$1.5M

from 1 investors over 1 rounds

B

BioCrossroads raised $1.5M on December 4, 2018

Investors: Richard M. Fairbanks Foundation

FAQ